Navigation Links
HLTH Corporation Announces Third Quarter Financial Results
Date:10/30/2008

ELMWOOD PARK, N.J., Oct. 30 /PRNewswire-FirstCall/ -- HLTH Corporation (Nasdaq: HLTH) today announced financial results for the three months ended September 30, 2008.

Martin J. Wygod, Chairman and Acting Chief Executive Officer of HLTH Corporation, said: "WebMD, HLTH's 84% owned subsidiary, continues to demonstrate its strength as the leading source of health information for consumers and health care professionals. WebMD's third quarter advertising sales, which we believe is an early indicator for 2009 growth, suggests our customers are looking to more aggressively integrate online strategies into their core marketing mix to both consumer and healthcare professionals in 2009."

Consolidated Financial Highlights

Revenue for the third quarter was $100.4 million, an increase of 17% over the prior year. Earnings before interest, taxes, non-cash and other items ("Adjusted EBITDA") for the third quarter was $22.5 million, an increase of 23% over the prior year. Income from continuing operations for the third quarter was $2.6 million or $0.01 per share. Income from discontinued operations was $93.2 million or $0.50 per share and net income was $95.9 million or $0.51 per share.

At September 30, 2008, HLTH had approximately $1.66 billion in cash and investments, of which $332.6 million is attributable to WebMD.

Segment Operating Results

Online Services segment revenue was $94.6 million for the third quarter compared to $79.6 million in the prior year period, an increase of 19%. Advertising and sponsorship revenue increased 22%, from the prior year period, to $72.0 million. Private portal licensing revenue increased 11%, from the prior year period, to $22.1 million. Online Services segment Adjusted EBITDA increased 18% to $26.0 million compared to $21.9 million in the prior year period.

Traffic to the WebMD Health Network continued to grow strongly with an average of 49.9 million unique users per month and total traffic of 1.14 billion page views during the third quarter, increases of 22% and 33%, respectively, from a year ago. In the third quarter, 1.3 million continuing medical education (CME) programs were completed on the WebMD Professional Network, an increase of 76% from the prior year period.

The base of large employers and health plans utilizing WebMD's private Health and Benefits portals during the third quarter was 129 as compared to 112 a year ago. During the quarter, WebMD significantly expanded its relationship with Wal-Mart Stores, Inc. and added Tyco International Management Company, Viacom, Inc., Presbyterian Health Plan, Inc. and Golden Living to its customer base.

Publishing and Other Services segment revenue was $5.8 million for the third quarter compared to $6.5 million in the prior year period, a decrease of 11% primarily related to weakness in the Company's Little Blue Book print product for physicians. Publishing and Other Services segment Adjusted EBITDA was $1.2 million compared to $2.1 million in the prior year period.

Discontinued Operations

HLTH's financial results present the ViPS and Porex businesses as discontinued operations in the current and prior year periods, reflecting the sale of ViPS and the decision to divest Porex. The sale of the ViPS business was completed on July 22, 2008 for $225 million in cash, which resulted in a gain of approximately $92 million, net of income taxes during the current quarter. WebMD's offline professional medical reference and textbook publication business is presented as a discontinued operation in the prior year period, reflecting the sale of that business on December 31, 2007.

Financial Guidance

WebMD provided financial guidance for the three months ending December 31, 2008 and for the year ending December 31, 2009 in a separate press release issued by WebMD and in a Form 8-K filed by WebMD today. HLTH is not providing consolidated financial guidance at this time.

Analyst and Investor Conference Call

As previously announced, HLTH and WebMD will host a conference call at 4:45 pm (Eastern) today to discuss their respective third quarter results. Investors can access the call via webcast at http://www.hlth.com (in the Investor Relations section). A replay of the call will be available at the same web address.

About HLTH

HLTH Corporation (Nasdaq: HLTH) owns approximately 84% of WebMD Health Corp. (Nasdaq: WBMD). WebMD is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through its public and private online portals and health-focused publications. HLTH also owns Porex, a developer, manufacturer and distributor of proprietary porous plastic products and components used in healthcare, industrial and consumer applications.

All statements contained in this press release and the related analyst and investor conference call, other than statements of historical fact, are forward-looking statements, including those regarding: our guidance on HLTH's and WebMD's future financial results and other projections or measures of their future performance; market opportunities and WebMD's ability to capitalize on them; the benefits expected from new products or services and from other potential sources of additional revenue; expectations regarding the market for WebMD's and HLTH's investments in auction rate securities (ARS); and the potential sale transaction with respect to Porex (the "Potential Porex Transaction"). These statements speak only as of the date of this press release, are based on HLTH's and WebMD's current plans and expectations, and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of WebMD's products and services; WebMD's relationships with customers and strategic partners; changes in the markets for ARS; and changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and plastics industries. Further information about these matters can be found in our other Securities and Exchange Commission filings. In addition, there can be no assurances regarding whether HLTH will be able to complete the Potential Porex Transaction or as to the timing or terms of such transaction. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

This press release, and the accompanying tables, include both financial measures in accordance with accounting principles generally accepted in the United States of America, or GAAP, as well as certain non-GAAP financial measures. The tables attached to this press release include reconciliations of these non-GAAP financial measures to GAAP financial measures. In addition, an "Explanation of Non-GAAP Financial Measures" is attached to this press release as Annex A.

WebMD(R), WebMD Health(R) and POREX(R) are trademarks of HLTH Corporation or its subsidiaries.

-Tables Follow-

HLTH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Revenue $100,367 $86,034 $271,185 $235,112

Costs and expenses:

Cost of operations 35,323 30,021 99,656 87,636

Sales and marketing 26,439 22,459 77,729 67,258

General and administrative 22,929 25,718 67,254 81,111

Depreciation and amortization 7,265 7,390 21,468 20,954

Interest income 9,386 10,864 29,384 30,638

Interest expense 4,636 4,660 13,871 13,985

Gain on sale of EBS Master LLC - - 538,024 -

Impairment of auction rate

securities - - 60,108 -

Other (expense) income, net (997) 989 (5,807) 5,267

Income from continuing

operations before income

tax provision 12,164 7,639 492,700 73

Income tax provision 7,679 2,977 34,623 4,404

Minority interest in WHC

income (loss) 1,845 1,800 (929) 2,758

Equity in earnings of EBS

Master LLC - 8,005 4,007 22,679

Income from continuing

operations 2,640 10,867 463,013 15,590

Income (loss) from discontinued

operations, net of tax 93,241 5,704 93,159 (38,780)

Net income (loss) $95,881 $16,571 $556,172 $(23,190)

Basic income (loss) per common

share:

Income from continuing operations $0.01 $0.06 $2.53 $0.09

Income (loss) from discontinued

operations 0.51 0.03 0.51 (0.22)

Net income (loss) $0.52 $0.09 $3.04 $(0.13)

Diluted income (loss) per

common share:

Income from continuing operations $0.01 $0.06 $2.06 $0.08

Income (loss) from discontinued

operations 0.50 0.03 0.41 (0.21)

Net income (loss) $0.51 $0.09 $2.47 $(0.13)

Weighted-average shares

outstanding used in

computing income (loss) per

common share:

Basic 183,716 179,811 182,838 178,681

Diluted 187,527 188,071 228,653 188,486

HLTH CORPORATION

CONSOLIDATED SEGMENT INFORMATION

(In thousands, except per share data, unaudited)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Revenue

WebMD Online Services:

Advertising and sponsorship $72,046 $59,087 $190,494 $158,944

Licensing 22,139 20,001 65,928 59,915

Content syndication and

other 392 490 1,154 2,027

Total WebMD Online Services 94,577 79,578 257,576 220,886

WebMD Publishing and Other

Services 5,810 6,520 13,669 14,426

Inter-segment eliminations (20) (64) (60) (200)

$100,367 $86,034 $271,185 $235,112

Earnings before interest, taxes,

non-cash and other items

("Adjusted EBITDA") (a)

WebMD Online Services $25,956 $21,948 $61,287 $48,982

WebMD Publishing and Other

Services 1,212 2,138 1,485 2,643

Corporate (4,679) (5,811) (15,311) (18,874)

$22,489 $18,275 $47,461 $32,751

Adjusted EBITDA per diluted

common share (b) $0.12 $0.10 $0.21 $0.17

Interest, taxes,

non-cash and other

items (c)

Interest income $9,386 $10,864 $29,384 $30,638

Interest expense (4,636) (4,660) (13,871) (13,985)

Income tax provision (7,679) (2,977) (34,623) (4,404)

Depreciation and

amortization (7,265) (7,390) (21,468) (20,954)

Non-cash stock-based

compensation (6,531) (9,285) (18,974) (26,246)

Non-cash advertising (178) (169) (1,736) (2,489)

Minority interest in WHC

(income) loss (1,845) (1,800) 929 (2,758)

Equity in earnings of EBS

Master LLC - 8,005 4,007 22,679

Gain on sale of EBS

Master LLC - - 538,024 -

Impairment of auction rate

securities - - (60,108) -

Other (expense) income, net (1,101) 4 (6,012) 358

Income from

continuing operations 2,640 10,867 463,013 15,590

Income (loss) from

discontinued operations,

net of tax 93,241 5,704 93,159 (38,780)

Net income (loss) $95,881 $16,571 $556,172 $(23,190)

Basic income

(loss) per common

share:

Income from continuing

operations $0.01 $0.06 $2.53 $0.09

Income (loss) from

discontinued operations 0.51 0.03 0.51 (0.22)

Net income (loss) $0.52 $0.09 $3.04 $(0.13)

Diluted income

(loss) per common

share:

Income from continuing

operations $0.01 $0.06 $2.06 $0.08

Income (loss) from

discontinued operations 0.50 0.03 0.41 (0.21)

Net income (loss) $0.51 $0.09 $2.47 $(0.13)

Weighted-average

shares outstanding used

in computing income (loss) per

common share:

Basic 183,716 179,811 182,838 178,681

Diluted 187,527 188,071 228,653 188,486

(a) See Annex A -- Explanation of Non-GAAP Financial Measures.

(b) Adjusted EBITDA per diluted common share is based on the

weighted-average shares outstanding used in computing diluted income

(loss) per common share.

(c) Reconciliation of Adjusted EBITDA to income from continuing

operations.

HLTH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, unaudited)

September 30, 2008 December 31, 2007

Assets

Cash and cash equivalents $1,380,179 $536,879

Short-term investments 284,789 290,858

Accounts receivable, net 78,148 86,081

Due from EBS Master LLC - 1,224

Prepaid expenses and other current

assets 27,190 71,090

Assets of discontinued operations 119,891 262,964

Total current assets 1,890,197 1,249,096

Marketable equity securities 2,175 2,383

Property and equipment, net 51,766 49,554

Goodwill 211,414 217,323

Intangible assets, net 28,917 36,314

Investment in EBS Master LLC - 25,261

Other assets 36,534 71,466

Total Assets $2,221,003 $1,651,397

Liabilities and Stockholders' Equity

Accrued expenses $44,305 $49,598

Deferred revenue 81,740 76,401

Liabilities of discontinued

operations 100,464 123,131

Total current liabilities 226,509 249,130

Convertible notes 650,000 650,000

Other long-term liabilities 21,184 21,137

Minority interest in WHC 139,250 131,353

Stockholders' equity 1,184,060 599,777

Total Liabilities and Stockholders'

Equity $2,221,003 $1,651,397

HLTH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

Nine Months Ended

September 30,

2008 2007

Cash flows from operating activities:

Net income (loss) $556,172 $(23,190)

Adjustments to reconcile net income (loss)

to net cash provided by operating

activities:

(Income) loss from discontinued

operations, net of tax (93,159) 38,780

Depreciation and amortization 21,468 20,954

Minority interest in WHC (loss) income (929) 2,758

Equity in earnings of EBS Master LLC (4,007) (22,679)

Amortization of debt issuance costs 2,248 2,179

Non-cash advertising 1,736 2,489

Non-cash stock-based compensation 18,974 26,246

Deferred income taxes 11,934 3,710

Gain on sale of EBS Master LLC and 2006

EBS Sale (538,024) (399)

Impairment of auction rate securities 60,108 -

Changes in operating assets and

liabilities:

Accounts receivable 7,932 14,835

Prepaid expenses and other, net 4,174 (198)

Accrued expenses and other

long-term liabilities (3,639) (45,878)

Deferred revenue 5,340 3,253

Net cash provided by continuing

operations 50,328 22,860

Net cash provided by discontinued

operations 28,497 24,366

Net cash provided by operating

activities 78,825 47,226

Cash flows from investing activities:

Proceeds from maturities and sales of

available-for-sale securities 117,539 356,492

Purchases of available-for-sale securities (177,150) (694,522)

Purchases of property and equipment (15,115) (14,427)

Proceeds related to the sales of ViPS,

EBS, EPS and ACS/ACP, net of expenses 821,706 14,565

Decreases in net advances to EBS Master LLC 1,224 19,921

Other 148 -

Net cash provided by (used in)

continuing operations 748,352 (317,971)

Net cash used in discontinued

operations (4,265) (3,785)

Net cash provided by (used in)

investing activities 744,087 (321,756)

Cash flows from financing activities:

Proceeds from issuance of HLTH and WHC

common stock 20,725 114,077

Purchases of treasury stock under

repurchase program - (47,120)

Other 343 (18)

Net cash provided by continuing

operations 21,068 66,939

Net cash used in discontinued

operations (76) (130)

Net cash provided by financing

activities 20,992 66,809

Effect of exchange rates on cash (604) 1,042

Net increase (decrease) in cash and cash

equivalents 843,300 (206,679)

Cash and cash equivalents at beginning of

period 536,879 614,691

Cash and cash equivalents at end of period $1,380,179 $408,012

ANNEX A

Explanation of Non-GAAP Financial Measures

The accompanying HLTH Corporation press release and financial tables include both financial measures in accordance with U.S. generally accepted accounting principles, or GAAP, as well as non-GAAP financial measures. The non-GAAP financial measures represent earnings before interest, taxes, non-cash and other items (which we refer to as "Adjusted EBITDA") and related per share amounts. Adjusted EBITDA should be viewed as supplemental to, and not as an alternative for, "income (loss) from continuing operations" or "net income (loss)" calculated in accordance with GAAP. The tables attached to the accompanying press release include reconciliations of non-GAAP financial measures to GAAP financial measures.

Adjusted EBITDA is used by HLTH's management as an additional measure of HLTH's overall performance and its reporting segments' performance for purposes of business decision-making, including developing budgets, managing expenditures, and evaluating potential acquisitions or divestitures. Period-to-period comparisons of Adjusted EBITDA help HLTH's management identify additional trends in HLTH's and its reporting segments' financial results that may not be shown solely by period-to-period comparisons of income (loss) from continuing operations or net income (loss). In addition, HLTH uses Adjusted EBITDA in the incentive compensation programs applicable to many of its employees in order to evaluate HLTH's performance. HLTH management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature. In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in income (loss) from continuing operations or net income (loss), as well as trends in those items. The amounts of those items are set forth, for the applicable periods, in the reconciliations of Adjusted EBITDA to income (loss) from continuing operations or to net income (loss) that accompany our press releases containing non-GAAP financial measures, including the reconciliations contained in the tables attached to the accompanying press release.

HLTH believes that the presentation of Adjusted EBITDA is useful to investors in their analysis of HLTH's results for reasons similar to the reasons why HLTH's management finds it useful and because it helps facilitate investor understanding of decisions made by HLTH's management in light of the performance metrics used in making those decisions. In addition, as more fully described below, HLTH believes that providing Adjusted EBITDA, together with a reconciliation of Adjusted EBITDA to income (loss) from continuing operations or to net income (loss), helps investors make comparisons between HLTH and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation. However, Adjusted EBITDA is intended to provide a supplemental way of comparing HLTH with other public companies and is not intended as a substitute for comparisons based on "income (loss) from continuing operations" or "net income (loss)" calculated in accordance with GAAP. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable SEC rules.

The following is an explanation of the items excluded by HLTH from Adjusted EBITDA but included in income (loss) from continuing operations in the accompanying press release:

-- Depreciation and Amortization. Depreciation and amortization expense is

a non-cash expense relating to capital expenditures and intangible

assets arising from acquisitions that are expensed on a straight-line

basis over the estimated useful life of the related assets. HLTH

excludes depreciation and amortization expense from Adjusted EBITDA

because it believes (i) the amount of such expenses in any specific

period may not directly correlate to the underlying performance of

HLTH's business operations and (ii) such expenses can vary

significantly between periods as a result of new acquisitions and full

amortization of previously acquired tangible and intangible assets.

Accordingly, HLTH believes this exclusion assists management and

investors in making period-to-period comparisons of operating

performance. Investors should note that the use of tangible and

intangible assets contributed to revenue in the periods presented and

will contribute to future revenue generation and should also note that

such expense will recur in future periods.

-- Stock-Based Compensation Expense. Stock-based compensation expense is a

non-cash expense arising from the grant of stock-based awards to

employees. HLTH believes that excluding the effect of stock-based

compensation from Adjusted EBITDA assists management and investors in

making period-to-period comparisons in its operating performance because

it believes (i) the amount of such expenses in any specific period may

not directly correlate to the underlying performance of HLTH's

business operations and (ii) such expenses can vary significantly

between periods as a result of the timing of grants of new stock-based

awards, including grants in connection with acquisitions. Additionally,

HLTH believes that excluding stock-based compensation from Adjusted

EBITDA assists management and investors in making meaningful comparisons

between HLTH's operating performance and the operating performance

of other companies that may use different forms of employee compensation

or different valuation methodologies for their stock-based compensation.

Investors should note that stock-based compensation is a key incentive

offered to employees whose efforts contributed to the operating results

in the periods presented and are expected to contribute to operating

results in future periods. Investors should also note that such

expenses will recur in the future.

-- Non-Cash Advertising Expense. This expense relates to the usage of

non-cash advertising obtained from News Corporation

("Newscorp") in exchange for equity securities issued by HLTH

in 2000. The advertising is available only on various Newscorp

properties, primarily its television network and cable channels without

any cash cost to HLTH. The amount of advertising that can be used in any

year is subject to annual contractual limitation and expires in 2010.

HLTH does not incur any other cash expenses related to airing of

television advertising. HLTH excludes this expense from Adjusted EBITDA

(i) because it is a non-cash expense, (ii) because it is incremental to

other non-television cash advertising expense that HLTH otherwise

incurs, (iii) because HLTH has not and believes it will not incur cash

expenses relating to television advertising in the future and (iv) to

assist management and investors in comparing its operating results over

multiple periods. Investors should note that it is likely that HLTH

derives some benefit from such advertising and that such expenses will

recur in the future.

-- Interest Income and Expense. Interest income is associated with the

level of marketable debt securities and other interest bearing accounts

in which HLTH invests, as well as with interest expenses arising from

the capital structure of HLTH. Interest income and expense varies over

time due to a variety of financing transactions and due to acquisitions

and divestitures that HLTH has entered into or may enter into in the

future. HLTH has, in the past several years, issued convertible

debentures and preferred stock, repurchased shares in cash tender offers

and through other repurchase transactions, conducted an initial public

offering of equity in its WebMD subsidiary and completed the divestiture

of certain businesses. HLTH excludes interest income and interest

expense from Adjusted EBITDA (i) because these items are not directly

attributable to the performance of HLTH's business operations and,

accordingly, their exclusion assists management and investors in making

period-to-period comparisons of operating performance and (ii) to assist

management and investors in making comparisons to companies with

different capital structures. Investors should note that interest income

and expense will recur in future periods.

-- Income Tax Provision. HLTH had net operating loss (NOL) carryforwards

of approximately $1.3 billion as of the year ended December 31, 2007.

HLTH maintained a full valuation allowance on these NOL carryforwards

until the fourth quarter of 2007, at which time a portion of the

valuation allowance was reversed after consideration of the relevant

factors. The related valuation allowances are either reversed through

the income statement, additional paid-in capital, or reversed to

goodwill, to the extent those tax benefits were acquired through

business combinations. The timing of such reversals has not been

consistent and as a result, HLTH's income tax expense can fluctuate

significantly from period to period in a manner not directly related to

HLTH's operating performance. HLTH excludes the income tax

provision from Adjusted EBITDA (i) because it believes that the income

tax provision is not directly attributable to the underlying performance

of HLTH's business operations and, accordingly, its exclusion

assists management and investors in making period-to-period comparisons

of operating performance and (ii) to assist management and investors in

making comparisons to companies with different tax attributes.

Investors should note that income tax provision will recur in future

periods.

-- Minority Interest in WHC. This represents the minority

stockholders' proportionate share of net income or loss of

HLTH's majority-owned WebMD Health Corp. subsidiary (which we refer

to as WHC). The size of this Minority Interest is related to

HLTH's percentage ownership of WHC. Changes in that percentage

ownership may result from changes in WHC's capital structure,

including as a result of sales of WHC equity securities by WHC or HLTH

or as a result of exercise of WHC employee stock options. HLTH excludes

Minority Interest from Adjusted EBITDA (i) because it believes that the

size of the Minority Interest can vary for reasons not attributable to

the underlying performance of HLTH's business operations and,

accordingly, its exclusion assists management and investors in making

period-to-period comparisons of operating performance and (ii) to assist

management and investors in making comparisons to companies with

different capital structures. Investors should note that Minority

Interest in WHC will recur in future periods.

-- Other Items. HLTH engages in other activities and transactions that can

impact HLTH's overall income from continuing operations. These

other items included, but were not limited to, (i) legal expenses

relating to the on-going Department of Justice investigation, (ii)

equity in earnings of EBS Master LLC, which represents 48% of EBS's

income through February 8, 2008, (iii) working capital adjustment from

the sale of 52% of the Emdeon Business Services segment on November 16,

2006, (iv) a reduction of certain sales and use tax contingencies

resulting from the expiration of certain applicable statutes of

limitations, (v) advisory expenses relating to the evaluation, in 2008

and 2007, by HLTH's Board of Directors of strategic alternatives

for HLTH, (vi) gain on sale from the sale of the remaining 48% ownership

interest in EBS Master LLC, and (vii) loss on the impairment of auction

rate securities. HLTH excludes these other items from Adjusted EBITDA

because it believes these activities or transactions are not directly

attributable to the performance of HLTH's business operations and,

accordingly, their exclusion assists management and investors in making

period-to-period comparisons of operating performance. Investors should

note that some of these other items may recur in future periods.


'/>"/>
SOURCE HLTH Corporation
Copyright©2008 PR Newswire.
All rights reserved


Related medicine news :

1. Alsius Corporation to Host Third Quarter 2008 Financial Results Conference Call on November 6
2. Deloitte Names Heska Corporation to Colorado Technology Fast 50
3. AMERIGROUP Corporation to Present at the 17th Annual Credit Suisse Healthcare Conference on November 13
4. Webcast Alert: Air Methods Corporation Announces Third Quarter 2008 Financial Results
5. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
6. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
7. Berger & Montague Announces Class Action Lawsuit Against Elan Corporation
8. Infinity Property and Casualty Corporation Declares Quarterly Dividend
9. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
10. DURECT Corporation to Participate in Upcoming Healthcare Conferences
11. Cardiogenesis Corporation to Report Third Quarter 2008 Results on November 13th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... FOR INFORMATION: ... AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference is the ... perioperative nurses in attendance to study the latest evidence-based recommendations and resources ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Today, the Whole-Food ... announced that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, ... Network. , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... announce the addition of micro-needling services in their Napa Valley office. The technique ... of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... SAN DIEGO , Feb. 5, 2016 Aethlon ... Jim Joyce , Chairman and CEO, will be presenting at ... New York, NY at 2:15 p.m. ... participate in an Immunotherapy Panel discussion taking place at 3:15 ... available for replay approximately one hour after the conclusion of ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... announced underwritten secondary offering of 11,027,558 shares of its ... affiliates of Blackstone and Goldman Sachs.  The shares are ... of $96.45 per share. The selling stockholders will receive ... Biomet nor any of its directors, officers or other ...
Breaking Medicine Technology: